The Prospect of Identifying Resistance Mechanisms for Castrate-Resistant Prostate Cancer Using Circulating Tumor Cells: Is Epithelial-to-Mesenchymal Transition a Key Player?

Khan, Tanzila; Scott, Kieran F; Becker, Therese M; Lock, John; Nimir, Mohammed; Ma, Yafeng; de Souza, Paul

Khan, Tanzila; Scott, Kieran F; Becker, Therese M; Lock, John; Nimir, Mohammed; Ma, Yafeng; de Souza, Paul.

Afiliação

Khan T; School of Medicine, Western Sydney University, Campbelltown, NSW 2560, Australia.
Scott KF; Medical Oncology, Ingham Institute of Applied Medical Research, Liverpool, NSW 2170, Australia.
Becker TM; Centre of Circulating Tumour Cells Diagnostics & Research, Ingham Institute of Applied Medical Research, Liverpool, NSW 2170, Australia.
Lock J; School of Medicine, Western Sydney University, Campbelltown, NSW 2560, Australia.
Nimir M; Medical Oncology, Ingham Institute of Applied Medical Research, Liverpool, NSW 2170, Australia.
Ma Y; School of Medicine, Western Sydney University, Campbelltown, NSW 2560, Australia.
de Souza P; Medical Oncology, Ingham Institute of Applied Medical Research, Liverpool, NSW 2170, Australia.

Prostate Cancer ; 2020: 7938280, 2020.

Article em En | MEDLINE | ID: mdl-32292603

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Prostate Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Austrália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Prostate Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Austrália